AUM$1.4M
Expense Ratio0.65%
NAV$6.72
Holdings2
InceptionSep 25, 2020
Price Chart
Key Statistics
Previous Close
N/ADay Range
N/A52-Week Range
N/AAvg Volume
N/ADividend Yield
N/AExpense Ratio
0.65%AUM
$1.4MShares Outstanding
N/ASector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.16% |
| Basic Materials | 0.84% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Issuer
- Global X
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Sep 25, 2020
- Description
- The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China’s biotechnology industry. It is non-diversified.
Similar ETFs
The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund issued by Global X that launched on Sep 25, 2020. It currently manages $1.4M in assets under management. The fund charges an expense ratio of 0.65%. The fund holds 2 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | CASH | 99.98% | 1,408,912 | $1.4M |
| 2 | — | OTHER PAYABLE & RECEIVABLES | 0.02% | -325 | $-325 |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | N/A | — | ||
| 1W | N/A | — | ||
| 1M | N/A | — | ||
| 3M | N/A | — | ||
| 6M | N/A | — | ||
| YTD | N/A | — | ||
| 1Y | N/A | — | ||
| 3Y | -28.88% | — | ||
| 5Y | -56.99% | — |
Moving Averages
20-Day MA
N/A
50-Day MA
N/A
200-Day MA
N/A
Price with Moving Averages
Support & Resistance
52-Week High
N/A
Current Price
N/A
52-Week Low
N/A
Current Yield
N/A
Annual Dividend
N/A
Frequency
N/A
Last Ex-Date
N/A
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | CHB | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.65% | 0.60% | 0.84% |
| AUM | $1.4M | $1.25B | $1.62B |
| Dividend Yield | — | 2.75% | 14.38% |
| Avg Volume | N/A | 769.9K | 1.3M |
| Holdings | 2 | 182 | 67 |
| Performance | |||
| 1-Month Return | — | -3.02% | -2.05% |
| 6-Month Return | — | +5.85% | +15.05% |
| YTD Return | — | +0.17% | +1.05% |
| 1-Year Return | — | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with CHB: